RNA干扰沉默缺氧诱导因子1α逆转肺癌细胞耐药性

目的：观察RNA干扰沉默缺氧诱导因子1α（HIF-1α）对肺癌细胞耐药性的影响。方法：构建靶向HIF-1α小干扰RNA基因，并转染到人肺腺癌耐顺铂细胞株A549／DDP细胞中。逆转录聚合酶链反应RT—PCR）检测细胞的HIF-1α、多药耐药基因-（MDR-1）以多药耐药相关蛋白基因（MRP）mRNA变化，免疫细胞化学法观察干扰后HIF-1α、P-糖蛋白以及MRP蛋白的变化。MTT法检测不同浓度的顺铂作用下细胞死亡率。结果：HIF-1αsiRNA组中H1F-1α、MDR—1、MRPmRNA水平显著降低（P〈0．05）。且蛋白水平也显著下降（P〈0．05）。HIF-1αsiRNA组细胞死亡率较未转染组均明显增高（P〈0．05），转染siRNA阴性组不影响肿瘤细胞的耐药性。结论：HIF-1αsiRNA可显著降低A549／DDP细胞中H1F-1α、MDR-1、MRP表达，从而起到逆转肺腺癌A549／DDP细胞的耐药作用。

Reversing the Multidrug Resistance of Human Pulmonary Adenocarcinoma Cells by RNA Interference Targeting HIF-1 alpha Gene

Objective： To reverse the multidrug resistant （MDR） phenotype of human lung cancer cells by small interference RNA （siRNA） technique targeting hypoxia-inducible factor-1α （HIF-1α） gene. Methods： Small interference RNA eukaryotic expression vector targeting HIF-1αgene was constructed and transfected into human adenocarcinoma A549/DDP cells by liposome technique. The mRNA and protein expression levels of HIF-1α, MDR-1 and MRP were investigated by RT-PCR and immuocytochemistry. The mortality of cells was observed by MTT in different groups treated with cisplatin of different concentrations. Results： mRNA and protein levels of HIF-1α, MDR-1 and MRP were significantly decreased in HIF-1α siRNA group. The MTT assays showed the mortality in HIF-1α siRNA group was significantly higher than that in non-transfected group （P 〈0.05）. The negative siRNA transfection did not affect the resistance of tumor cells. Conclusion： HIF-1α siRNA significantly reduced the expression ofHIF-1α, MDR-1 and MRP in A549/DDP cells and thus played a role in reversing drug resistance.